{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T14:19:54Z","timestamp":1788013194400,"version":"build-2784847793"},"reference-count":20,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2021,7]]},"abstract":"Abstract<\/jats:title>\n \n Introduction<\/jats:title>\n Widely varying rates of alloimmunization associated with transfusing uncrossmatched RBC products to trauma patients as part of hemostatic resuscitation have been reported. We characterized the rates of RBC alloimmunization in our severely injured Rh(D) negative trauma population who received uncrossmatched Rh(D) positive RBC products.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n In a 10\u2010year retrospective analysis to assess Rh(D) alloimmunization risks, Rh(D) negative adult trauma patients initially requiring uncrossmatched group O Rh(D) positive RBC products with either RBC units or low titer group O whole blood as part of massive transfusion protocol (MTP) activation were identified. Only those Rh(D) negative patients whose initial antibody screenings were negative were included. Duration of serologic follow\u2010up from date of MTP activation to either date of anti\u2010D detection or most recent negative antibody screening was calculated.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n There were 129 eligible Rh(D) negative trauma patients identified. Median injury severity score was 25. Anti\u2010D was detected in 10 (7.8%) patients after a median of 161.5\u2009days; the median duration of serologic follow\u2010up in those who did not have anti\u2010D detected was 220\u2009days. Patients who had anti\u2010D detected were less severely injured and received fewer Rh(D) positive RBC products versus those who did not.<\/jats:p>\n <\/jats:sec>\n \n Discussion<\/jats:title>\n In our severely injured adult trauma patients with MTP activation requiring uncrossmatched group O Rh(D) positive RBC products, the rate of anti\u2010D detection was low. Additional studies are necessary to determine generalizability of these findings and fully characterize alloimmunization risks in trauma patients with varying extents of injury.<\/jats:p>\n <\/jats:sec>","DOI":"10.1111\/trf.16493","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T09:13:28Z","timestamp":1626426808000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Anti\u2010D<\/scp>\n alloimmunization in Rh(D) negative adults with severe traumatic injury"],"prefix":"10.1111","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9835-957X","authenticated-orcid":false,"given":"Jay S.","family":"Raval","sequence":"first","affiliation":[{"name":"Department of Pathology University of New Mexico Albuquerque New Mexico USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Madden","sequence":"additional","affiliation":[{"name":"Department of Pathology University of New Mexico Albuquerque New Mexico USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Neal","sequence":"additional","affiliation":[{"name":"Department of Surgery University of Pittsburgh Pittsburgh Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Surgery University of New Mexico Albuquerque New Mexico USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2013.02.008"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15569"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.21307\/immunohematology-2019-110"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30051-0"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1159\/000485388"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2019.09.005"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15182"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00394.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2012.03659.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12875"},{"issue":"4","key":"e_1_2_6_12_1","first-page":"40A","article-title":"RBC alloantibody formation is not associated with RBC age in adult sickle cell disease patients receiving chronic apheresis RBC exchange","volume":"56","author":"Randall C","year":"2016","journal-title":"Transfusion"},{"key":"e_1_2_6_13_1","first-page":"105","article-title":"RBC alloantibody formation is not associated with RBC age in pediatric sickle cell disease patients receiving chronic apheresis RBC exchange","volume":"32","author":"Crimmins J","year":"2017","journal-title":"J Clin Apher"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.6.2283-2291.1997"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-199806000-00017"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02116.x"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2013.01.001"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.452"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13696"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14547"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000001905"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.16493","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/trf.16493","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.16493","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T17:28:49Z","timestamp":1693330129000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.16493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":20,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1111\/trf.16493"],"URL":"https:\/\/doi.org\/10.1111\/trf.16493","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"2020-12-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}